KYTX
Kyverna Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$8.95
+0.18 ▲ +2.05%
🌙 3월 13일 7:30 PM ET (한국 3/14 08:30)
$9.10
+0.15 ▲ +1.68%
| Index | - | P/E | - | EPS (ttm) | -3.72 | Insider Own | 42.06% | Shs Outstand | 0.04B | Perf Week | 10.49% |
| Market Cap | 0.51B | Forward P/E | - | EPS next Y | 6.11% | Insider Trans | 1.02% | Shs Float | 0.03B | Perf Month | 18.54% |
| Enterprise Value | 0.35B | PEG | - | EPS next Q | -0.85 | Inst Own | 44.92% | Short Float | 12.66% | Perf Quarter | 9.41% |
| Income | -0.16B | P/S | - | EPS this Y | -10.93% | Inst Trans | 27.55% | Short Ratio | 2.77 | Perf Half Y | 115.66% |
| Sales | 0.00B | P/B | 2.58 | EPS next 5Y | 1.16% | ROA | -61.17% | Short Interest | 4.19M | Perf YTD | -4.79% |
| Book/sh | 3.47 | P/C | 2.99 | EPS past 3/5Y | -75.88% - | ROE | -70.82% | 52W High | -34.53% ($13.67) | Perf Year | 258% |
| Cash/sh | 3 | P/FCF | - | Sales past 3/5Y | - | ROIC | -105.03% | 52W Low | 402.81% ($1.78) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -21.22% | Gross Margin | - | Volatility(W/M) | 8.62% 6.93% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.64 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 5.16 | EPS Q/Q | -6.05% | Profit Margin | - | RSI (14) | 56.45 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.16 | Sales Q/Q | - | SMA20 | 8.74% ($8.23) | Beta | 2.92 | Target Price | $29.6 |
| Payout | - | Debt/Eq | 0.03 | Earnings | 11000000 | SMA50 | 6.72% ($8.39) | Rel Volume | 0.37 | Prev Close | $8.77 |
| Employees | 112 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | 12.47% - | SMA200 | 47.73% ($6.06) | Avg Volume(3M) | 1.51M | Price | $8.95 |
| IPO | 2024/2/8 | Option/Short | Yes/Yes | Trades | 7501 | Volume | 561,173 | Change | 2.05% |
뉴스 로딩 중...